Market Report Coverage – Minimally Invasive Surgical Systems
- Market Segmentation
- Regional Segmentation
- Market Growth Drivers
- Market Challenges
- Market Opportunities
- Key Companies Profiled
- How This Report Can Add Value
- Who should buy this report?
- Key questions answered in the Report
- Minimally Invasive Surgical Systems Market Overview
- Market Drivers
- Market Challenges
- Market Opportunities
- Impact of COVID-19
- Market Segmentation
- Key Market Players and Competition Synopsis
• Product – Conventional Technologies (Endoscopes and Endoscopic Systems, Video and Visualization Systems, Capsule Endoscopy, Instruments and Accessories, Others), Surgical Robotics (Robotic Systems, Instruments and Accessories, Services)
• Application – General Surgery, Urology Surgery, Gynecology Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery, Others (Cosmetic and Bariatric Surgery)
• End User – Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics
• Region – North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
• North America – U.S., Canada
• Europe – Germany, France, Spain, U.K., Italy, Netherlands, Belgium, Switzerland, Sweden, Denmark, Rest-of-Europe
• Asia-Pacific – Japan, South Korea, India, China, Australia and New Zealand, Malaysia, Singapore, Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, Argentina, Rest-of-Latin America
• Middle East and Africa – Kingdom of Saudi Arabia (K.S.A.), United Arab Emirates (U.A.E.), Israel, Rest-of-Middle East and Africa
Market Growth Drivers
• Rising Incidence of Chronic Diseases
• Advantages Over Open Surgeries
• Increase in Global Geriatric Population
• Increasing Healthcare Costs
• Technological Advancements in Surgical Procedures and Technologies
• High Cost of Minimally Invasive Surgical Robotic Systems
• Shortage of Skilled Professionals
• Restrictive Reimbursement Landscape
• Engage in Mergers and Acquisitions to Diversify Endoscopic Portfolio
• Development of Surgical Simulators for the Training of Professionals
• Development of Low-Cost Surgical Robotic Systems
Key Companies Profiled
Arthrex Inc., Asensus Surgical, Inc., Boston Scientific Corporation, Conmed Corporation, Fujifilm Holdings Corporation, Intuitive Surgical, Inc., Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Hoya Corporation (Pentax Medical), Siemens Healthineers AG, Smith & Nephew plc, Sony Corporation, Stryker Corporation, Zimmer Biomet Holdings, Inc.
How This Report Can Add Value
Who should buy this report?
• Surgical Instruments and Accessories (both Conventional MISS and Surgical Robotics) OEMs to gain a holistic view of the market potential of various systems and the developing economies for business expansions.
• Surgical Robotics Manufacturers
• Endoscopes, Endoscopic Systems, Capsule Endoscopy Manufacturers
• Established medical technology companies to gain insights about the market potential, market entry strategies, new technologies in the market, and key competitors.
• Medical Research Institutions
• Healthcare Facilities
• Specialty Clinics
Key questions answered in the Report
• What are the key regulations governing the minimally invasive surgical systems market, across the globe?
• What are the key technological developments on which the current industry leaders are spending their major share of research and development (R&D) investment?
• How is the role of minimally invasive surgery technologies expected to evolve in the future?
• Who are the leading players who hold significant dominance on the global minimally invasive surgical systems market, currently?
• How likely are current business models to persist in the future?
• What are the key market drivers, challenges, growth opportunities, and trends?
• How do minimally invasive procedures function as compared to each other?
• How is the expiration of patents likely to disrupt the market dynamics?
• What are the key strategies incorporated by the leading players in the minimally invasive surgical systems landscape?
• What is the likelihood of new players entering the market in the near term?
• What is the current revenue contribution for different endoscopes and endoscopy systems, and what are the expected modifications in the forecast period?
• What is the current revenue contribution for the different types of conventional minimally invasive surgical systems, and what are expected modifications in the same forecast period?
• What is the current revenue contribution for the different types of surgical robotic systems, and what are the expected modifications in the same forecast period?
• Which countries contribute to the major share of current demand and which countries hold significant scope for business expansion activities, by the key players?
Minimally Invasive Surgical Systems Market Overview
As per the National Cancer Institute, minimally invasive surgery is defined as, “surgery that is done using small incisions (cuts) and few stitches. During minimally invasive surgery, one or more small incisions may be made in the body.
A laparoscope (thin, tube-like instrument with a light and a lens for viewing) is inserted through one opening to guide the surgery. Tiny surgical instruments are inserted through other openings to do the surgery. Minimally invasive surgery may cause less pain, scarring, and damage to healthy tissue, and the patient may have a faster recovery than with traditional surgery.”
As per the U.S. Food and Drug Administration (FDA), “Different types of computer-assisted surgical systems can be used for pre-operative planning, surgical navigation, and to assist in performing surgical procedures. Robotically assisted surgical (RAS) devices are one type of computer-assisted surgical system.
Sometimes referred to as robotic surgery, RAS devices enable the surgeon to use computer and software technology to control and move surgical instruments through one or more tiny incisions in the patient’s body (minimally invasive) for a variety of surgical procedures.”
The global minimally invasive surgical systems market is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031.
Presently, the factors driving the growth of the market as per the minimally invasive surgical systems report include rising incidence of chronic diseases, increase in global geriatric population, advantages of MIS over open surgeries, increasing healthcare costs, technological advancements in surgical procedures and technologies.
The challenges that are restricting the growth of the market include the high cost of surgical robotics systems, shortage of skilled professionals, and restrictive reimbursement landscape.
The high cost of the surgical robotic system is among the most challenging factors for the end-user to buy and treat for patients. It has been observed that many patients prefer international travel for their surgeries to take the advantage of the currency rate.
Also, the shortage of skilled professionals has led to a slight increase in the expense of the robotic surgery. The restrictive reimbursement landscape is another factor affecting the growth of the global minimally invasive surgical systems market.
Potential opportunities that are likely to boost the growth of the market include the development of low-cost surgical robotic systems, the development of surgical simulators for the training of professionals, and engagement in mergers and acquisitions to diversify the endoscopic portfolio.
The current radiation therapy systems have a price of around $2 million, therefore many companies are working in developing cost-effective systems and even working towards the development of a low-cost surgical robotic platform. And with time, technologically advanced products are being worked on, researched to get an upgraded product.
Impact of COVID-19
The COVID-19 pandemic had a huge impact on elective surgical procedures in the first half of 2020. The COVID-19 pandemic has drastically impacted the daily hospital routine services on the global level. During the initial phase of the pandemic, hospitals greatly reduced or canceled conducting elective surgical procedures for patient safety and to prioritize the care treatments for patients with COVID-19.
The reduction in the volume of elective surgical procedures on a large scale had a substantial impact on patients as well as a financial impact on the medical device manufacturers. This resulted in the decreased sales of the minimally invasive surgical systems.
Minimally Invasive Surgical Systems Market (by Product Type)
Under this segmentation, the market is divided into conventional technologies and surgical robotics.
The conventional technologies segment dominates the market with a share of 80.4% of the global minimally invasive surgical systems market mainly due to the increase in the number of minimally invasive surgical procedures.
The surgical robotics segment is expected to register a higher CAGR than the external beam radiation segment, the CAGR is 10.2% during the forecast period.
Minimally Invasive Surgical Systems Market (by Application)
Under this segmentation, the market is divided into general surgery, urology surgery, orthopedic surgery, cardiovascular surgery, neurosurgery, others (cosmetic and bariatric surgery)
These above-mentioned applications are based on conventional technologies and the surgical robotics segment.
Orthopedic surgery under the conventional technology segment is expected to register the highest CAGR of 7.0% during the forecast period.
Minimally Invasive Surgical Systems Market (by End-User)
Under this segmentation, the market is divided into hospitals, ambulatory surgical centers (ASCs), specialty clinics.
The hospitals segment dominates the minimally invasive surgical systems market with a share of 73.3% of the global market mainly due to the number of hospitals providing access to surgical treatments for the patients.
Ambulatory surgical centers (ASCs) segment is expected to register the highest CAGR of 8.0% during the forecast period.
Minimally Invasive Surgical Systems Market (by Region)
The different regions covered under the market report include North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America dominates the market in 2020 and is anticipated to uphold its dominance throughout the forecast period. The growth in the market is majorly driven by the increasing research and development activities and many companies being located in the U.S.
Latin America, and the Middle East and Africa markets are expected to grow with the highest CAGR of 7.8% during the forecast period.
Key Market Players and Competition Synopsis
Some of the key players operating in the market, include Arthrex Inc., Asensus Surgical, Inc., Boston Scientific Corporation, Conmed Corporation, Fujifilm Holdings Corporation, Intuitive Surgical, Inc., Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Hoya Corporation (Pentax Medical), Siemens Healthineers AG, Smith & Nephew plc, Sony Corporation, Stryker Corporation, and Zimmer Biomet Holdings, Inc.
The minimally invasive surgical systems market has witnessed several strategic and technological developments from January 2017- July 2021, undertaken by the different market players to attain their respective market shares in this emerging domain.
Some of the strategies covered in this segment are product development and upgradations, partnerships, collaborations, business expansions, funding activities, regulatory approvals, mergers, and acquisitions. The preferred strategy for companies has been partnerships, collaborations, and business expansions.